Stephens Inc. AR Has $2.05 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Stephens Inc. AR cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 11.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,444 shares of the biotechnology company’s stock after selling 442 shares during the quarter. Stephens Inc. AR’s holdings in Axon Enterprise were worth $2,047,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of AXON. Public Sector Pension Investment Board boosted its holdings in Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the period. CIBC Asset Management Inc lifted its stake in shares of Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the period. Foundations Investment Advisors LLC acquired a new stake in Axon Enterprise during the third quarter worth about $221,000. Sequoia Financial Advisors LLC increased its stake in Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at approximately $814,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Down 1.3 %

NASDAQ AXON opened at $669.26 on Wednesday. The stock’s 50 day simple moving average is $624.25 and its 200 day simple moving average is $501.43. Axon Enterprise, Inc. has a one year low of $255.68 and a one year high of $698.67. The firm has a market cap of $51.03 billion, a PE ratio of 172.94, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insiders Place Their Bets

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the transaction, the president now owns 181,892 shares in the company, valued at $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on AXON. JMP Securities lifted their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 4th. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Finally, Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.